Pharmafile Logo

Speak First

Speak First is all about three things – confidence, impact and clarity. Our communication skills training and coaching is guaranteed to enhance business relationships. With over 20 years’ experience, we are global specialists in soft skills training essential for business success. Our expertise include: presentation skills, personal impact, media training, selling and negotiation skills, business writing, NLP for Business and other interpersonal and communication skills training to improve workplace effectiveness and career success.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Amiculum

AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…

View Profile

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.

View Profile

M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Company Details

1st Floor, 20 Old Street, London, EC1V 9AB, United Kingdom
+44 (0)20 7253 2117

 Latest Content from PMHub 

6 trends shaping the future of personalized medicine

Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators.

Virtual product launch planning: the ultimate playbook

We walk you through, step-by-step, how cross-functional teams can seamlessly work together and overcome the many obstacles associated with traditional product launches.

Innovative Trials opens first US office

We are incredibly excited to announce the opening of our very first US office! This is an incredible milestone towards our mission to accelerate clinical development. Read the full press...

Artificial Intelligence for Identifying and Monitoring Cognitive Decline

Liam Kaufman, CEO & Co-founder of Winterlight Labs, explores a range of topics related to AI, machine learning, natural language processing, digital biomarkers, and human-computer interactions in healthcare.

OPEN Health to acquire leading US medical communications platform The CM Group from NaviMed Capital

Press Releases | July 28, 2022 | OPEN Health

OPEN Health, a pre-eminent global provider of scientific communications and market access services, announced that it signed a binding agreement to acquire The CM Group, a leading US domestic medical...

Be Patient

Awareness raising is key to boosting patient involvement and engendering trust.

Abstract Highlights from EHA 2022 : A Spotlight on CLL

Spotlight on CLLAhead of EHA 2022, Medscape Education Chief Medical Officer, Hansa Bhargava, MD, caught up with Prof John Gribben, UK, on the most important abstracts to look out for in...

Abstract Highlights from EHA 2022 : A Spotlight on Lymphoma

Spotlight on LymphomaAhead of EHA 2022, Medscape Education Chief Medical Officer, Hansa Bhargava, MD, caught up with Dr Loretta Nastoupil, US, on the most important abstracts to look out for in...

Trust and transparency in Pharma & healthcare: impact of the COVID-19 pandemic

While it is obvious that trust in life science and healthcare companies is suboptimal, exactly how to improve the public’s trust is unclear...